Cofoe Medical Technology's controlling shareholder, Xingzhao Investment, has increased its holding of 1,324,400 H shares.

date
21:08 20/07/2026
avatar
GMT Eight
Kangfu Medical (01187) announced that recently, the company received a notification from its controlling shareholder, Xiezi Hao Investment, that on July 17, 2026, Xiezi Hao Investment increased its H shares of the company by 1.3244 million shares. This led to Xiezi Hao Investment and its concerted action parties, Changsha Keyuan Tongchuang Entrepreneurship Investment Partnership Enterprise (limited partnership) (hereinafter referred to as "Keyuan Tongchuang"), Zhang Min, and Nie Juan, collectively increasing their shareholding proportion from 47.82% to 48.38%, and the change in shareholding touched on a multiple of 1%.
Cofoe Medical Technology (01187) announced that recently, the company received a notification from the controlling shareholder, Dari Investment, that on July 17, 2026, Dari Investment increased its H shares in the company by 1.3244 million shares. This resulted in Dari Investment and its concerted actor Changsha Keyuan Tongchuang Venture Investment Partnership Enterprise (Limited Partnership) (referred to as "Keyuan Tongchuang"), Zhang Min, and Nie Juan collectively holding a total of 48.38% of the shares, up from 47.82%. The shareholding change triggered a situation where the shareholding changed by a multiple of 1%.